Revolution Medicines, Inc. (RVMD)
176.35
-4.35
(-2.41%)
USD |
NASDAQ |
Nov 12, 16:00
176.07
-0.28
(-0.16%)
After-Hours: 06:39
Revolution Medicines Market Cap : 38.14B for Nov. 12, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 12, 2026 | 38.14B |
| November 11, 2026 | 39.08B |
| November 10, 2026 | 41.75B |
| November 09, 2026 | 43.28B |
| November 06, 2026 | 41.58B |
| November 05, 2026 | 38.42B |
| November 04, 2026 | 43.19B |
| November 03, 2026 | 42.00B |
| November 02, 2026 | 40.69B |
| October 30, 2026 | 40.99B |
| October 29, 2026 | 40.76B |
| October 28, 2026 | 40.43B |
| October 27, 2026 | 39.90B |
| October 26, 2026 | 39.40B |
| October 23, 2026 | 40.06B |
| October 22, 2026 | 40.21B |
| October 21, 2026 | 41.62B |
| October 20, 2026 | 42.11B |
| October 19, 2026 | 39.02B |
| October 16, 2026 | 38.13B |
| October 15, 2026 | 40.55B |
| October 14, 2026 | 41.46B |
| October 13, 2026 | 40.37B |
| October 12, 2026 | 41.55B |
| October 09, 2026 | 40.65B |
| Date | Value |
|---|---|
| October 08, 2026 | 40.30B |
| October 07, 2026 | 43.03B |
| October 06, 2026 | 42.82B |
| October 05, 2026 | 44.49B |
| October 02, 2026 | 44.27B |
| October 01, 2026 | 44.11B |
| September 30, 2026 | 43.98B |
| September 29, 2026 | 43.81B |
| September 28, 2026 | 43.22B |
| September 25, 2026 | 43.91B |
| September 24, 2026 | 42.82B |
| September 23, 2026 | 40.86B |
| September 22, 2026 | 41.32B |
| September 21, 2026 | 41.30B |
| September 18, 2026 | 40.91B |
| September 17, 2026 | 42.19B |
| September 16, 2026 | 41.97B |
| September 15, 2026 | 43.89B |
| September 14, 2026 | 43.94B |
| September 11, 2026 | 43.66B |
| September 10, 2026 | 43.57B |
| September 09, 2026 | 44.49B |
| September 08, 2026 | 44.42B |
| September 04, 2026 | 45.00B |
| September 03, 2026 | 45.18B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Moderna, Inc. | 93.47B |
| Arrowhead Pharmaceuticals, Inc. | 6.655B |
| Oncolytics Biotech, Inc. | 46.37M |
| Intellia Therapeutics, Inc. | 1.480B |
| Twist Bioscience Corp. | 7.159B |
Market Cap Related Metrics
| PS Ratio | 183.13 |
| PEG Ratio | -0.2564 |
| Price to Book Value | 15.88 |
| Price | 176.35 |
| Earnings Yield | -5.16% |
| PEGY Ratio | -0.2564 |